Sara Healy is an Endocrinology/Metabolic physician affiliated with Augusta University. OpenAlex indexes 11 publications with 308 citations (h-index 5); ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1120 15th St # Hb-5025
Augusta, GA 309124296
Telephone
706-721-2131Provider last certified this registry record 10 Feb 2021.
Clinical trials
- Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Overall officialCompletedNCT02544048 - Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B...
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Overall officialPhase 1CompletedNCT02511054 - Assessing Human-to-Mosquito Transmission in Volunteers Participating in Malaria Vaccine Candidate Trials in Mali
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Overall officialCompletedNCT02206451
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tandem Diabetes Care, Inc.Program year20251 payment
- Sequel Med Tech, LLCProgram year20251 payment
- Aurinia Pharma U.S., Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
79.1%Insulin Analog33.5%Novolog Flexpen22%Lantus Solostar17%Tresiba Flextouch U-20012%Fiasp Flextouch12%Basaglar Kwikpen U-10011%Humalog Kwikpen U-10010%Humalog7%Tresiba Flextouch U-1006%Toujeo Solostar5%Part D<11 patientsGLP-1 receptor agonist27.3%Ozempic69%Trulicity17%Mounjaro15%Part D<11 patients+ 3 more classes in this area
Hormonal (systemic)
17.8%l-Thyroxine13.6%Levothyroxine Sodium74%Synthroid26%Part D<11 patientsThyroid Hormone Synthesis Inhibitor4.2%Methimazole100%Part D<11 patientsCardiovascular
3.1%PCSK9 Inhibitor1.7%Repatha Sureclick100%Part D<11 patientsOther lipid modifying agents1.4%Vascepa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Weintraub, MD
Augusta University
Satish Rao, MD
Augusta University
Avirup Guha, MBBS
Augusta University
Satish S.C. Rao
Augusta University
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”